Maravai LifeSciences Holdings, Inc. Class A Common Stock (MAR)
FSX
Real-time Data
06:00 AM
Day's Range
6.2552 wk Range
2.32Overview - MAR - Maravai LifeSciences Holdings, Inc. Class A Common Stock
Key Statistics
Valuation
Enterprise Value
1.12B
P/E (Trailing)
‪35.00‬
P/E (Forward)
‪5.03‬
PEG Ratio
‪-0.49‬
Price / Sales (TTM)
‪11.79‬
Price / Book
‪5.62‬
EV / EBITDA
‪-64.94‬
Profitability
Gross Margin
‪40.14%‬
Profit Margin
‪-37.06%‬
Operating Margin
‪-29.39%‬
Return on Assets
‪-5.70%‬
Return on Equity
‪-33.04%‬
Ownership
Shares Outstanding
148.88M
Float
114.21M
Held by Insiders
‪7.25%‬
Held by Institutions
‪96.78%‬
Price stats
Beta
‪0.60‬
50-Day Avg
‪6.03‬
200-Day Avg
‪4.08‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - MAR - Maravai LifeSciences Holdings, Inc. Class A Common Stock
Peers - MAR - Maravai LifeSciences Holdings, Inc. Class A Common Stock
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- MARFSXMaravai LifeSciences Holdings, Inc. Class A Common Stock2.46BMarket Cap+60.30%52-week change35.00P/E (Trailing)‪-37.06%‬Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)‪29.78%‬Profit Margin
- 0QFFSXModerna Inc.69.12BMarket Cap+87.76%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 64BFSXAstera Labs, Inc.53.43BMarket Cap+42.53%52-week change179.66P/E (Trailing)‪30.74%‬Profit Margin
- 1AEFSXargenx SE52.63BMarket Cap+28.29%52-week change36.62P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt50.36BMarket Cap+25.47%52-week change34.88P/E (Trailing)‪32.26%‬Profit Margin
- 42ZFSXRevolution Medicines, Inc.37.58BMarket Cap+78.78%52-week change-29.47P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - MAR - Maravai LifeSciences Holdings, Inc. Class A Common Stock
About
Maravai LifeSciences Holdings, Inc. Class A Common Stock represents ownership in Maravai LifeSciences Holdings, Inc., a life sciences company focused on products and services that support drug development, vaccine creation, cell and gene therapy research, and diagnostics. The company serves biopharmaceutical,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
